Skip to main content
Category

Biopharmacy

admin
In Biopharmacy, Full Member, I

InnoSer

As an innovative and dynamic contract research organization (CRO) InnoSer supports the preclinical pipeline from its facilities in Belgium and the Netherlands. Founded in 2012, our in-depth expertise allows us to provide customized and streamlined early drug development options with well-characterized and near-patient research models. Our services are designed with...
Read More
admin
In Biopharmacy, Full Member, H

Hyloris Pharmaceuticals

Hyloris is a specialty biopharma company identifying and unlocking hidden potential in existing medications for the benefit of patients, physicians, and the healthcare systems. Hyloris applies its knowhow and technological innovations to existing pharmaceuticals and has built a broad, patented portfolio of reformulated and repurposed value-added products that have the...
Read More
admin
In Biopharmacy, Full Member, G

GSK

GSK is a science-led global healthcare company with a special purpose: to help people do more, feel better, live longer. GSK Vaccines is one of the largest vaccine manufacturers with a portfolio of more than 30 vaccines. In Belgium, GSK integrates all operations from research to development (preclinical and clinical),...
Read More
admin
In Biopharmacy, E, Full Member

Exothera SA

Exothera is a full-service CDMO (Contract Development and Manufacturing Organization) delivering customized process development and GMP (Good Manufacturing Practices) manufacturing services for gene therapy and viral vector-based vaccines. As a Univercells company, Exothera provides best-in-class bioprocessing expertise that capitalizes on novel manufacturing technologies. The company delivers accelerated process development/optimization to rapidly reach...
Read More
admin
In Biopharmacy, E, Full Member

Equaly SA

Equaly is a start-up rooted on innovative science for applications in the treatment of immunological disorders. We are developing and licensing treatment solutions based on patent-protected technology platforms aiming at 1) eliminating immunogenicity of therapeutic biologicals, 2) generating target-specific cytoxic cells to eradicate intracellular infections and tumors 3) modulating innate...
Read More